State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Dia-Jie Street, Fengtai, Beijing 100071, China.
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Dia-Jie Street, Fengtai, Beijing 100071, China.
Vaccine. 2014 Apr 11;32(18):2027-33. doi: 10.1016/j.vaccine.2014.02.057. Epub 2014 Feb 28.
Rickettsia rickettsii is the pathogen of Rocky Mountain spotted fever (RMSF), a life-threatening tick-transmitted infection. Adr2 was a surface-exposed adhesion protein of R. rickettsii and its immunoprotection against RMSF was investigated in mice.
Recombinant Adr2 (rAdr2) was used to immunize C3H/HeN mice, and the rickettsial loads in organs of the mice were detected after challenge with R. rickettsii. The levels of specific antibodies of sera from the immunized mice were determined and the sera from immunized mice were applied to neutralize R. rickettsii. Proliferation and cytokine secretion of CD4(+) and CD8(+) T cells isolated from R. rickettsii-infected mice were also assayed after rAdr2 stimulation.
After R. rickettsii challenge, the rickettsial loads in spleens, livers, and lungs were significantly lower and the impairment degrees of these organs in rAdr2-immunized mice were markedly slighter, compared with those in negative control mice. The ratio of specific IgG2a/IgG1 of rAdr2-immunized mice kept increasing during the immunization. After treatment with rAdr2-immunized sera, the total number of R. rickettsii organisms adhering and invading host cells was significantly lower than that treated with PBS-immunized sera. Interferon-γ secretion by CD4(+) or CD8(+) T cells and tumor necrosis factor-α secretion by CD4(+) T cells from R. rickettsii-infected mice were respectively significantly greater than those from uninfected mice after rAdr2 stimulation.
Adr2 is a protective antigen of R. rickettsii. Protection offered by Adr2 is mainly dependent on antigen-specific cell-mediated immune responses, including efficient activity of CD4(+) and CD8(+) T cells to produce great amount of TNF-α and/or IFN-γ as well as rapid increase of specific IgG2a, which synergistically activate and opsonize host cells to killing intracellular rickettsiae.
立氏立克次体是落矶山斑点热(RMSF)的病原体,这是一种危及生命的蜱传感染。Adr2 是立氏立克次体表面暴露的黏附蛋白,其对 RMSF 的免疫保护作用在小鼠中进行了研究。
使用重组 Adr2(rAdr2)免疫 C3H/HeN 小鼠,用立氏立克次体攻击后检测小鼠器官中的立克次体负荷。检测免疫小鼠血清中的特异性抗体水平,并将免疫小鼠的血清用于中和立氏立克次体。还检测了 rAdr2 刺激后从感染立氏立克次体的小鼠分离的 CD4(+)和 CD8(+)T 细胞的增殖和细胞因子分泌。
用立氏立克次体攻击后,rAdr2 免疫小鼠的脾、肝和肺中的立克次体负荷明显降低,这些器官的损伤程度明显减轻,与阴性对照小鼠相比。rAdr2 免疫小鼠的特异性 IgG2a/IgG1 比值在免疫过程中持续增加。用 rAdr2 免疫血清处理后,黏附并侵入宿主细胞的立氏立克次体总数明显低于用 PBS 免疫血清处理的细胞。rAdr2 刺激后,感染立氏立克次体的 CD4(+)或 CD8(+)T 细胞产生的干扰素-γ和 CD4(+)T 细胞产生的肿瘤坏死因子-α的数量分别明显高于未感染的小鼠。
Adr2 是立氏立克次体的保护性抗原。Adr2 提供的保护主要依赖于抗原特异性细胞免疫反应,包括 CD4(+)和 CD8(+)T 细胞的有效活性,产生大量 TNF-α和/或 IFN-γ,以及特异性 IgG2a 的快速增加,这协同激活和调理宿主细胞以杀死细胞内立克次体。